Value Sharing with Management and Employees through Restricted Stock Compensation and Performance-Linked Stock Acquisition Rights
First written in FY2018-Q1. 12 of 17 entries say "Advanced", first in FY2018. Latest entry: FY2026-H1.
- FY2026-H1AdvancedAnnual report
「19 January 2026 (Note) 27,873 9,547,580 Note: Shares issued through a paid-in third-party allotment as restricted stock compensation. Issue price: ¥735 Amount transferred to capital: ¥367.50 Allottees: Directors other than outside directors, executive officers and employees, and employees of subsidiaries」
As restricted stock compensation, 27,873 shares were issued on 19 January 2026 and allotted to directors other than outside directors, executive officers and employees, and employees of subsidiaries. - FY2025AdvancedAnnual report
「Paid-in third-party allotment as restricted stock compensation, with 16 January 2025 as the payment date」
The company continued to grant restricted stock compensation and issued 32,955 shares on 16 January 2025. The recipients were 2 directors, 9 executive officers and employees of the company, and 5 employees of subsidiaries. - FY2024AdvancedAnnual report
「For the current consolidated fiscal year, against planned consolidated operating profit of ¥450 million and EBITDA of ¥1,300 million, actual consolidated operating profit was ¥789 million and EBITDA was ¥1,618 million, resulting in achievement rates of 176% and 125%, respectively.」
Disclosure of achievement rates of 176% for consolidated operating profit and 125% for EBITDA against the performance metrics linked to restricted stock compensation. - FY2024-Q1AdvancedAnnual report
「Due to the capital increase resulting from the issuance of new shares as restricted stock compensation, with 16 January 2024 as the payment date, the total number of shares issued as of the filing date increased by 21,611 shares, while capital and capital reserves each increased by ¥6 million.」
Disclosure that new shares were issued as restricted stock compensation, with 16 January 2024 as the payment date, increasing shares issued by 21,611 and capital and capital reserves by ¥6 million each. - FY2023Disclosure of the FY2023 achievement rate for performance-linked compensationAnnual report
「For the current consolidated fiscal year, against planned consolidated operating profit of ¥800 million and EBITDA of ¥1,640 million, actual consolidated operating profit was ¥341 million and EBITDA was ¥1,150 million, resulting in achievement rates of 43% and 70%, respectively.」
Disclosure of the planned figures, actual results and achievement rates for FY2023 operating profit and EBITDA as performance-linked metrics for restricted stock compensation. - FY2023-Q1AdvancedAnnual report
「Due to the capital increase resulting from the issuance of new shares as restricted stock compensation, with 16 January 2023 as the payment date, the total number of shares issued as of the filing date increased by 21,800 shares, while capital and capital reserves each increased by ¥6 million.」
New shares were issued as restricted stock compensation on 16 January 2023, and the increases in the total number of shares issued, capital and capital reserves as of the filing date were disclosed. - FY2022AdvancedAnnual report
「For the consolidated fiscal year, against planned consolidated operating income of ¥940 million and EBITDA of ¥1,810 million, actual consolidated operating income was ¥707 million and EBITDA was ¥1,548 million, representing achievement rates of 75% and 86%, respectively.」
Disclosure of the planned figures, actual results and achievement rates for FY2022 consolidated operating profit and EBITDA as performance-linked metrics for restricted stock compensation. - FY2022-Q1AdvancedAnnual report
「Note 2. Due to the capital increase resulting from the issuance of new shares as restricted stock compensation, with 14 January 2022 as the payment date, the total number of shares issued as of the filing date increased by 19,830 shares, while capital and capital surplus each increased by ¥7 million.」
New shares were issued as restricted stock compensation, with 14 January 2022 as the payment date. As of the filing date, the total number of shares issued had increased by 19,830 shares, and capital and capital surplus had each increased by ¥7 million. - FY2021AdvancedAnnual report
「For the current consolidated fiscal year, against planned consolidated operating profit of ¥700 million and EBITDA of ¥1,563 million, actual consolidated operating profit was ¥576 million and EBITDA was ¥1,426 million, resulting in achievement rates of 82% and 91%, respectively.」
Disclosure of the planned figures, actual results and achievement rates for consolidated operating profit and EBITDA as performance-linked metrics for restricted stock compensation. - FY2021-Q2RestatedAnnual report
「15 January 2021 (Note) 1 17,631 9,273,511 Note 1. Shares issued through a paid-in third-party allotment as restricted stock compensation. Issue price: ¥981 Amount transferred to capital: ¥490.50 Allottees: Directors other than outside directors, and employees of subsidiaries」
Disclosure that 17,631 shares were issued as restricted stock compensation on 15 January 2021 and allotted to directors other than outside directors and employees of subsidiaries. - FY2021-Q1AdvancedAnnual report
「Note 2. The increase in the number of common shares issued as of the filing date is attributable to the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation, with 15 January 2021 as the payment date.」
Disclosure of an additional issuance of new shares as restricted stock compensation, with 15 January 2021 as the payment date. - FY2020Disclosure of performance-linked compensation metrics and achievement ratesAnnual report
「The metrics for variable compensation are consolidated operating profit and consolidated EBITDA (*), which are treated as important management indicators, and the Board of Directors determines the compensation based on the degree of achievement against the budget set at the beginning of the fiscal year.」
In addition to restricted stock compensation and other forms of compensation, the company discloses the use of achievement against the budgets for consolidated operating profit and consolidated EBITDA as metrics for variable compensation. - FY2020-Q1AdvancedAnnual report
「Through a capital increase resulting from the issue of new shares as restricted stock compensation, with 16 January 2020 as the payment date, the total number of shares issued as of the filing date increased by 8,822 shares, while both stated capital and capital surplus increased by ¥3 million.」
The Company disclosed an additional implementation of restricted stock compensation, with 8,822 shares issued on 16 January 2020. - FY2019RestatedAnnual report
「Paid third-party allotment as restricted stock compensation Issue price of the shares offered: ¥957 per share Total issue price: ¥13,385,559 Transfer restriction period: 16 January 2019–15 January 2020」
The annual report discloses the issue of 13,987 shares and the transfer restriction period under the restricted stock compensation plan for directors, subsidiary directors and executive officers, and employees. - FY2019-Q1AdvancedAnnual report
「At a meeting of the Company’s Board of Directors held on 19 December 2018, the Company resolved to issue new shares as restricted stock compensation, and the subscription payment procedures were completed on 16 January 2019.」
As restricted stock compensation, the Company issued 13,987 common shares on 16 January 2019, allocating 4,582 shares to 2 Company directors and 9,405 shares to 9 employees of the Company’s subsidiaries. The Company implemented an additional value-sharing initiative. - FY2018AdvancedAnnual report
「Paid third-party allotment as restricted stock compensation Issue price of the shares offered: ¥1,841 per share Total issue price: ¥12,354,951 Recipients and number of people allocated shares Company directors: 2 people, 2,611 shares Directors, executive officers, and employees of the Company’s subsidiaries: 8 people, 4,100 shares」
The Company implemented the restricted stock compensation plan approved in the previous fiscal year, allocating a total of 6,711 shares to 10 directors and subsidiary officers and employees. - FY2018-Q1First statedAnnual report
「At a meeting of the Company’s Board of Directors held on 29 November 2017, the Company resolved to introduce a stock compensation plan under which restricted stock would be granted to the Company’s directors, excluding outside directors, with the aim of increasing their awareness of contributing to improved performance and greater corporate value and promoting further value sharing with shareholders under the new management structure. On 16 January 2018, the Company issued 6,711 shares of its common stock. With the aim of expanding the Group’s performance and increasing corporate value over the medium to long term, the Company will issue paid stock acquisition rights to its directors and audit & supervisory board members, as well as the directors and employees of its subsidiaries, in order to further increase their motivation and morale and strengthen the Group’s cohesion.」
The Company introduced restricted stock compensation and paid stock options for directors, subsidiary officers, executive officers, and employees. Restricted stock totaling 6,711 shares was allocated to 10 people, with a transfer restriction period from 16 January 2018 to 15 January 2019. The Company issued 8,000 stock acquisition rights covering 800,000 shares, with the exercisable percentage set according to EBITDA achievement levels from the fiscal year ending September 2020 through the fiscal year ending September 2022.